Hopes Rise For SK’s COVID-19 Vaccine As It Moves To Comparative Phase III Trial

Korean Candidate A Global Contender?

 
• By Jung Won Shin
  
SK Bioscience R&D
SK’s COVID-19 Vaccine Developed With Unprecedented Global Support • Source: SK Bioscience
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from South Korea

More from Focus On Asia